219 related articles for article (PubMed ID: 8030708)
21. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
Babinszki A; Lapinski RH; Berkowitz RL
Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
[TBL] [Abstract][Full Text] [Related]
22. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
23. Maternal Kell blood group alloimmunization.
Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
[TBL] [Abstract][Full Text] [Related]
24. The role of sonography in assessing severity of fetal anemia in Rh- and Kell-isoimmunized pregnancies.
Chitkara U; Wilkins I; Lynch L; Mehalek K; Berkowitz RL
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):393-8. PubMed ID: 3126469
[TBL] [Abstract][Full Text] [Related]
25. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
[TBL] [Abstract][Full Text] [Related]
26. The significance of anti-Kell sensitization in pregnancy.
Mayne KM; Bowell PJ; Pratt GA
Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
[TBL] [Abstract][Full Text] [Related]
27. Severe Rh(D) immunization: anti-D quantitation and treatment possibilities during pregnancy and after birth.
Gottvall T; Hildén JO; Nelson N; Filbey D
Acta Paediatr; 1995 Nov; 84(11):1315-7. PubMed ID: 8580635
[TBL] [Abstract][Full Text] [Related]
28. Kell sensitization in pregnancy.
Caine ME; Mueller-Heubach E
Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
Collinet P; Subtil D; Puech F; Vaast P
Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
[TBL] [Abstract][Full Text] [Related]
30. Non-rhesus (D) blood group isoimmunization in obstetrics.
Beal RW
Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
[No Abstract] [Full Text] [Related]
31. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
Pessler F; Hart D
J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
[TBL] [Abstract][Full Text] [Related]
32. Derivated fetal haemoglobin as a marker for red cell age in the human fetus reflecting stimulated or impaired red blood cell production.
Huisman M; Egberts J; van Loon J
Prenat Diagn; 2001 Jul; 21(7):523-8. PubMed ID: 11494284
[TBL] [Abstract][Full Text] [Related]
33. Severe hemolytic disease of the newborn due to anti-Js(b).
Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
[TBL] [Abstract][Full Text] [Related]
34. Human fetal bilirubin levels and fetal hemolytic disease.
Weiner CP
Am J Obstet Gynecol; 1992 May; 166(5):1449-54. PubMed ID: 1595799
[TBL] [Abstract][Full Text] [Related]
35. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody.
Phung TV; Houfflin-Debarge V; Ramdane N; Ghesquière L; Delsalle A; Coulon C; Subtil D; Vaast P; Garabedian C
Transfusion; 2018 May; 58(5):1199-1205. PubMed ID: 29512164
[TBL] [Abstract][Full Text] [Related]
36. [Kell immunization--a case report].
Tasić M; Milosević J; Stefanović M; Radović-Janosević D; Krstić M; Antić V
Med Pregl; 2009; 62(7-8):369-72. PubMed ID: 19902791
[TBL] [Abstract][Full Text] [Related]
37. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
38. Management of red blood cell alloimmunization in pregnancy.
Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
Gottvall T; Hildén JO; Selbing A
Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
[TBL] [Abstract][Full Text] [Related]
40. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
